PARSABIV
Active substance: etelcalcetide
INJECTION, SOLUTION · ETELCALCETIDE HYDROCHLORIDE 2.5 mg/.5mL
United StatesActive
Marketing holder: Amgen, Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- ETELCALCETIDE HYDROCHLORIDE · 2.5 mg/.5mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-783d-7170-87d6-e09e598576d3,01a1208d-455c-7d70-a779-3139949ded0d,01a1208d-4560-7411-b98c-2357a5feb50b;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 55513-740
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 55513-740 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 55513-740 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 55513-740 · Verified 2026-10-09 · open in source